503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.97%
Net income growth under 50% of CRWD's 30.05%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
6.66%
D&A growth well above CRWD's 6.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
97.28%
Well above CRWD's 61.99% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
6.57%
Less SBC growth vs. CRWD's 13.23%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-85.12%
Both reduce yoy usage, with CRWD at -200.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
215.62%
AR growth while CRWD is negative at -124.34%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-414.07%
Negative yoy inventory while CRWD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-147.88%
Negative yoy AP while CRWD is 184.01%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-113.57%
Negative yoy usage while CRWD is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
96.88%
Well above CRWD's 14.15%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
13.04%
Some CFO growth while CRWD is negative at -13.35%. John Neff would note a short-term liquidity lead over the competitor.
6.61%
Lower CapEx growth vs. CRWD's 64.44%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
50.00%
Acquisition growth of 50.00% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-13.54%
Negative yoy purchasing while CRWD stands at 31.64%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
15.80%
We have some liquidation growth while CRWD is negative at -36.63%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
202.91%
We have some outflow growth while CRWD is negative at -9.26%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
6.31%
Lower net investing outflow yoy vs. CRWD's 52.10%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
65.29%
Debt repayment growth of 65.29% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
38.91%
We slightly raise equity while CRWD is negative at -200.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-45.61%
We cut yoy buybacks while CRWD is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.